Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Chem Res Toxicol ; 19(3): 376-81, 2006 Mar.
Article in English | MEDLINE | ID: mdl-16544941

ABSTRACT

17-Dimethylaminoethylamino-17-demethoxygeldanamycin (DMAG) and 17-allylamino-17-demethoxygeldanamycin (17-AAG) are two derivatives of geldanamycin (GA) that are currently undergoing clinical evaluation as anticancer agents. These agents bind to heat shock protein 90 (hsp90), resulting in the destabilization of client proteins and inhibition of tumor growth. In a search for the mechanism of hepatotoxicity, which is a dose-limiting toxicity for these agents, we found that GA and its derivatives, 17-AAG and 17-DMAG, react chemically (i.e., nonenzymatically) with glutathione (GSH). A combination of liquid chromatography/electrospray ionization/mass spectrometry and nuclear magnetic resonance analyses were used to identify the product of this reaction as a GSH adduct in which the thiol group of GSH is substituted in the 19-position of the benzoquinone ring. The reaction proceeds rapidly with GA and 17-DMAG (half-lives of approximately 1.5 and 36 min, respectively) and less rapidly with 17-AAG and its major metabolite, 17-AG (half-lives of approximately 9.8 and 16.7 h). The reaction occurs at pH 7.0, 37 degrees C, and a physiological concentration of GSH, indicating that cellular GSH could play a role in modulating the cellular toxicity of these agents and therefore be a factor in their mechanism of differential toxicity. Moreover, reactions with thiol groups of critical cellular proteins could be important to the mechanism of toxicity with this class of anticancer agents.


Subject(s)
Antibiotics, Antineoplastic/chemistry , Glutathione/chemistry , Quinones/chemistry , Benzoquinones , Buffers , Chromatography, High Pressure Liquid , Drug Stability , HSP90 Heat-Shock Proteins/chemistry , Lactams, Macrocyclic , Magnetic Resonance Spectroscopy , Mass Spectrometry , Phosphates/chemistry , Sulfhydryl Compounds/chemistry
2.
Bioorg Med Chem ; 14(1): 62-6, 2006 Jan 01.
Article in English | MEDLINE | ID: mdl-16143537

ABSTRACT

To aid in the clinical evaluation of zebularine, a potential oral antitumor agent, we initiated studies on the metabolism of zebularine in liver cytosol from humans and other mammals. Metabolism by aldehyde oxidase (AO, EC 1.2.3.1) was the major catabolic route, yielding uridine as the primary metabolite, which was metabolized further to uracil by uridine phosphorylase. The inhibition of zebularine metabolism was studied using raloxifene, a known potent inhibitor of AO, and 5-benzylacyclouridine (BAU), a previously undescribed inhibitor of AO. The Michaelis-Menten kinetics of aldehyde oxidase and its inhibition by raloxifene and BAU were highly variable between species.


Subject(s)
Aldehyde Oxidase/metabolism , Cytidine/analogs & derivatives , Cytosol/metabolism , Enzyme Inhibitors/pharmacology , Liver/metabolism , Aldehyde Oxidase/antagonists & inhibitors , Animals , Chromatography, High Pressure Liquid , Cytidine/metabolism , Cytosol/enzymology , Dogs , Female , Haplorhini , Humans , Liver/enzymology , Macaca fascicularis , Male , Mice , Rats
3.
Chem Biol Interact ; 142(1-2): 43-55, 2002 Nov 10.
Article in English | MEDLINE | ID: mdl-12399154

ABSTRACT

The quantification and identification of xenobiotic reactive intermediates is difficult in the absence of highly radiolabeled drug. We have developed a method for identifying these intermediates by measuring the formation of adducts to intracellularly generated radiolabeled glutathione (GSH). Freshly isolated adherent rat and human hepatocytes were incubated overnight in methionine and cystine-free ('thio-free') medium. They were then exposed to 100 microM methionine and 10 microCi 35S-labeled methionine in otherwise thio-free medium to replete cellular GSH pools with intracellularly generated 35S-labeled GSH. After 3 h, acetaminophen was added as a test compound and the cells were incubated for an additional 24 h. Intracellular GSH and its specific activity were quantified after reaction with monobromobimane followed by HPLC analysis with fluorescence and radiochemical detection. Radiolabeled GSH was detectable at 3 h and maintained high specific activity and physiological concentrations for up to 24 h. Incubation medium from acetaminophen treated and nontreated hepatocytes were analyzed for radiolabeled peaks by HPLC using radiochemical detection. Radiolabeled peaks not present in nontreated hepatocytes were identified as acetaminophen GSH adducts by LC-MS. Formation of acetaminophen 35S-GSH adducts by rat hepatocytes containing endogenously synthesized 35S-GSH was increased with acetaminophen concentrations ranging from 500 to 2 mM.


Subject(s)
Acetaminophen/pharmacology , Anti-Inflammatory Agents, Non-Steroidal/pharmacology , Glutathione/metabolism , Liver/metabolism , Methionine/metabolism , Acetaminophen/pharmacokinetics , Animals , Anti-Inflammatory Agents, Non-Steroidal/pharmacokinetics , Carbon Radioisotopes , Chromatography, Liquid , Cystine/metabolism , Hepatocytes/drug effects , Hepatocytes/metabolism , Humans , Mass Spectrometry , Rats , Sulfur Radioisotopes
SELECTION OF CITATIONS
SEARCH DETAIL
...